Insulet (Nasdaq:PODD) shares ticked up today on third-quarter results that came in well ahead of the consensus forecast.

The Espirit everolimus-eluting scaffold. [Image from the Abbott website] Abbott (NYSE:ABT) today announced data demonstrating ...

Tandem Diabetes Care shares ticked up after hours today on third-quarter results that topped the consensus forecast.

Que Dallara, EVP and president of Medtronic Diabetes, wrote on LinkedIn: ...

Beta Bionics announced today that it launched the integration of the iLet bionic pancreas with the Abbott (NYSE:ABT) ...

Senseonics (NYSE:SENS) shares dipped slightly before hours today on third-quarter results that came in mixed compared to the consensus forecast. Shares of SENS fell 2.5% to 34¢ apiece in pre-market ...

Tidepool today announced a new data integration with Abbott for the company's FreeStyle Libre continuous glucose monitors ...

Insulet (Nasdaq:PODD) today announced its plans to recognize National Diabetes Awareness Month and World Diabetes Day.

Abbott announced today that the FDA said users can wear the FreeStyle Libre 2 and 3 CGMs during common imaging procedures.

PharmaSens announced today that it appointed Dr. Robert A. Gabbay and James L. Peterson to its board of directors.

Senseonics (NYSE:SENS) announced today that it entered into a definitive agreement to offer $16 million in common stock.

Insulcloud today announced its strategic expansion into the U.S. following FDA clearance for its Insulclock CAP smart device.